About: http://webisa.webdatacommons.org/409923083

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The FDA has noted that there is a theoretical risk of arterial thrombotic events (ATEs) in anti-VEGF inhibitors - the class of drugs to which Lucentis and its rival
http://www.w3.org/ns/prov#wasQuotedFrom	ihs.com